ABT – abbott laboratories (US:NASDAQ)
Stock Stats
News
Rep. Julia Letlow Discloses Over 200 Stock Trades After Deadline As Ban Debate Grows In Congress [Forbes]
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $157.00 to $152.00. They now have a "buy" rating on the stock.
AI Optical Coherence Tomography Market Opportunities to 2029 & 2034 by Type, Technology, Application and Region [Yahoo! Finance]
Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins [Yahoo! Finance]
PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research [Yahoo! Finance]
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Stratton John G
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Roman Michael F
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Gonzalez Patricia Paola
Form 4 ABBOTT LABORATORIES For: Dec 31 Filed by: Alpern Robert J
Form 3 ABBOTT LABORATORIES For: Dec 12 Filed by: Ahuja Nita
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.